Allscripts Healthcare Solutions (MDRX)
Allscripts Healthcare Solutions Revenues: 364.71M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MDRX Revenues Rankings
| Overall | 69th percentile | 1344 of 4432 |
| Sector | 77th percentile | 188 of 845 in Technology |
| Industry | 75th percentile | 3 of 12 in Healthcare Information Services |
MDRX Revenues Range, Past 5 Years
| Minimum | -4.849M | Dec 2010 |
| Maximum | 383.18M | Dec 2011 |
| Average | 192.93M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these MDRX related companies
MDRX News
Wells Fargo Starts Allscripts (MDRX) at Market Perform; Long-term Growth Prospects Muted
May 29, 4:52PM Street Insider
May 29, 4:52PM Street Insider
$MDRX accumulation continues, many will chase this thru $12... Long, staying long. CEO resigns its $15, Buy out its $17-$20.
about 2 days ago by mentholatum
about 2 days ago by mentholatum
HealthCor Obtains Expedited Review by Delaware Court of Chancery for Lawsuit Against Allscripts
May 25, 2:08PM Benzinga
May 25, 2:08PM Benzinga
$MDRX Keeps tempting me. Support seems to be around 10.97 need to see it close above that. Really want to see it close above 11.26
about 7 days ago by tweetingstocks
about 7 days ago by tweetingstocks
Lazard Starts ATHN, CERN, QSII, MDAS at Buy, MDRX, OMCL, CPSI, EHTH at Neutral, EPOC at Sell
May 23, 8:56AM Street Insider
May 23, 8:56AM Street Insider
$MDRX watched trades all day. Bid on more call spreads and did not get. Look for upgrade as Accumulation is going on here by someone..
about 9 days ago by mentholatum
about 9 days ago by mentholatum
$MDRX-the sellers are gone, the buyers are thinking. A breakout about $11.50 shoots us to $13/$14. They're in line waiting to jump.
about 9 days ago by mentholatum
about 9 days ago by mentholatum
$MDRX Healthcor sues Allscripts in proxy fight attempt. This is a good thing by the way. No position held here yet. Been watching :)
about 10 days ago by tweetingstocks
about 10 days ago by tweetingstocks
$AAPL call spread looking good, $GLUU/$ZNGA watching for flush. $MDRX bot more calls, DEC '2012 Long $12 an Short the $17
about 10 days ago by mentholatum
about 10 days ago by mentholatum
$MDRX if a buyout was coming the price wld be in a uptrend Smart Money always has insight somewhere Buy for it being undervauled if anything
about 11 days ago by tweetingstocks
about 11 days ago by tweetingstocks
$MDRX knows they will get bought out setting here at this price... At what price...$17 to $19 is a steal. Loading up.
about 12 days ago by mentholatum
about 12 days ago by mentholatum
$MDRX Would $CERN buying Allscripts make sense? I'm starting to think so. Together they would dominate. Just something to think about.
about 13 days ago by tweetingstocks
about 13 days ago by tweetingstocks
$MDRX Pulled back again and trading below 10.86 support. I think the news yesterday is positive. Low volume. Will let everyone know if I buy
about 14 days ago by tweetingstocks
about 14 days ago by tweetingstocks
$MDRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3rS2
about 15 days ago by MarketBrief
about 15 days ago by MarketBrief
RT @mojoris1977 $MDRX 13D filing http://stks.co/3rOa Thanks explains the pop.
about 15 days ago by tweetingstocks
about 15 days ago by tweetingstocks
$MDRX on the ARNA board and missed a decent push down Pretty sure I will get another chance. If not I Will wait for it to break resistance
about 15 days ago by tweetingstocks
about 15 days ago by tweetingstocks
$MDRX Hits 10.86 support area. Watching this one closely for a nice push under from smart money and may get in. Will post if I do.
about 15 days ago by tweetingstocks
about 15 days ago by tweetingstocks
$MDRX My alert went off at $11. I would like to see a pullback to 10.86 area or push above 11.26 to consider buying. This is a $13 stock
about 16 days ago by tweetingstocks
about 16 days ago by tweetingstocks
$MDRX glad I did not get in yet. Seems to have 11.26 resistance on short term. will jump in if it can break that level.
about 20 days ago by tweetingstocks
about 20 days ago by tweetingstocks
Allscripts Healthcare Solutions Lawsuit Deadline Announced by Gilman Law LLP
May 09, 3:04PM Marketwire
May 09, 3:04PM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MDRX | 10.97 | -0.24 | -2.14% | 2.136B |
| MDR | 10.18 | -0.72 | -6.61% | 2.562B |
| MDP | 29.62 | +0.04 | +0.14% | 1.325B |
| OESX | 2.14 | +0.07 | +3.38% | 47.63M |
| OEH | 8.20 | -0.30 | -3.53% | 872.86M |
| ODP | 2.18 | -0.04 | -1.80% | 623.51M |
| ODFL | 43.36 | -1.31 | -2.93% | 2.566B |
| ODC | 19.86 | -0.46 | -2.26% | 104.04M |
| OCZ | 4.58 | -0.33 | -6.72% | 322.88M |
| OCR | 31.99 | -0.46 | -1.42% | 3.687B |